{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:21Z","timestamp":1793144001951,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["707034"],"award-info":[{"award-number":["707034"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ygyno.2024.12.010","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T08:57:41Z","timestamp":1735549061000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management"],"prefix":"10.1016","volume":"193","author":[{"given":"Andrea","family":"Neilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Talhouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2024.12.010_bb0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","article-title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019","volume":"161","author":"Gu","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.12.010_bb0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.010_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2024.12.010_bb0020","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.010_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2016.07.090","article-title":"Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment","volume":"143","author":"Talhouk","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2024.12.010_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100085","article-title":"Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death","volume":"36","author":"Jamieson","year":"2023","journal-title":"Mod. Pathol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.12.010_bb0035","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","article-title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","volume":"128","author":"Vermij","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.12.010_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2023.03.016","article-title":"Back to the future: the impact of oestrogen receptor profile in the era of molecular endometrial cancer classification","volume":"186","author":"Perrone","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.12.010_bb0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2023.01.025","article-title":"Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer","volume":"170","author":"Jamieson","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.010_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ijgc-2022-004039","article-title":"Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program","volume":"33","author":"R. R. Consortium","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"15","key":"10.1016\/j.ygyno.2024.12.010_bb0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2024.12.010_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123730","article-title":"CA125 and ovarian cancer: a comprehensive review","volume":"12","author":"Charkhchi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ygyno.2024.12.010_bb0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.26433","article-title":"The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer","volume":"131","author":"Nicklin","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.010_bb0070","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.5301\/JBM.2012.9346","article-title":"Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients","volume":"27","author":"Roelofsen","year":"2012","journal-title":"Int. J. Biol. Markers"},{"issue":"5","key":"10.1016\/j.ygyno.2024.12.010_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5468\/ogs.2013.56.5.281","article-title":"Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: the Asian experience 2000 to 2012","volume":"56","author":"Patsner","year":"2013","journal-title":"Obstetrics Gynecol. Sci."},{"issue":"5","key":"10.1016\/j.ygyno.2024.12.010_bb0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5468\/ogs.2015.58.5.385","article-title":"Prediction of lymph node metastasis in patients with apparent early endometrial cancer","volume":"58","author":"Son","year":"2015","journal-title":"Obstetrics & Gynecology Science"},{"issue":"5","key":"10.1016\/j.ygyno.2024.12.010_bb0085","article-title":"Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study","volume":"30","author":"Reijnen","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2024.12.010_bb0090","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/cancers15092605","article-title":"Preoperative CA125 significantly improves risk stratification in high-grade endometrial cancer","volume":"15","author":"Lombaers","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.010_bb0095","doi-asserted-by":"crossref","first-page":"19004","DOI":"10.1038\/s41598-022-23252-3","article-title":"Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer","volume":"12","author":"Asami","year":"2022","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.ygyno.2024.12.010_bb0100","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1158\/1078-0432.CCR-20-1268","article-title":"Endometrial Cancer molecular risk stratification is equally prognostic for Endometrioid ovarian carcinoma","volume":"26","author":"Kramer","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ygyno.2024.12.010_bb0105","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s00432-022-04218-4","article-title":"Improved preoperative risk stratification in endometrial carcinoma patients: external validation of the ENDORISK Bayesian network model in a large population-based case series","volume":"149","author":"Grube","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.010_bb0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2022.01.025","article-title":"Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.010_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2022.02.001","article-title":"Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.010_bb0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.010_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.010_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"International Journal of Gynecologic Cancer"},{"issue":"14","key":"10.1016\/j.ygyno.2024.12.010_bb0135","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cncr.33516","article-title":"Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: an individual patient data meta-analysis","volume":"127","author":"McAlpine","year":"2021","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2024.12.010_bb0140","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/ijgc-2024-005711","article-title":"SENECA study: staging endometrial cancer based on molecular classification","volume":"34","author":"Chacon","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2024.12.010_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112847","article-title":"Molecular classification to prognosticate response in medically managed endometrial cancers and endometrial intraepithelial neoplasia","volume":"13","author":"Puechl","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.ygyno.2024.12.010_bb0150","doi-asserted-by":"crossref","first-page":"12248","DOI":"10.3390\/ijms222212248","article-title":"Fertility sparing treatments in endometrial cancer patients: the potential role of the new molecular classification","volume":"22","author":"Cavaliere","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.12.010_bb0155","article-title":"Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia","volume":"241","author":"Zhang","year":"2023","journal-title":"Pathol. - Res. Pr."},{"key":"10.1016\/j.ygyno.2024.12.010_bb0160","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-23-1397","article-title":"Clinical behavior and molecular landscape of stage I p53-abnormal low-grade endometrioid endometrial carcinomas","author":"Jamieson","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.010_bb0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1186\/s12885-023-11234-1","article-title":"A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.010_bb0170","first-page":"299","article-title":"Racial\/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA","volume":"32","author":"Sasamoto","year":"2021","journal-title":"Cancer Causes Control"},{"issue":"26","key":"10.1016\/j.ygyno.2024.12.010_bb0175","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.2217\/fon-2019-0310","article-title":"Ethnic disparity in clinical performance between multivariate index assay and CA125 in detection of ovarian malignancy","volume":"15","author":"Dunton","year":"2019","journal-title":"Future Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2024.12.010_bb0180","doi-asserted-by":"crossref","first-page":"e880","DOI":"10.1634\/theoncologist.2019-0117","article-title":"Diagnostic accuracy of clinical biomarkers for preoperative prediction of lymph node metastasis in endometrial carcinoma: a systematic review and meta-analysis","volume":"24","author":"Reijnen","year":"2019","journal-title":"Oncologist"},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2024.12.010_bb0185","first-page":"A96","article-title":"234 addressing variation in preoperative workup of high-grade endometrial carcinoma","volume":"30","author":"Jamieson","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.12.010_bb0190","series-title":"WHO Classification of Tumours: Female Genital Tumours","article-title":"Tumours of the Ovary; Malignant endometrioid tumours","author":"Kobel","year":"2020"},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.010_bb0195","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2020.08.017","article-title":"A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1\/G2 endometrioid endometrial cancer","volume":"159","author":"Shen","year":"2020","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824012289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824012289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:57:39Z","timestamp":1773835059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824012289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":39,"alternative-id":["S0090825824012289"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.12.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}